- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03637933
Endoscopic Tattooing and Colorectal Cancer
Safety and Efficacy of Endoscopic Tattooing in Colorectal Surgery. India Ink vs Sterile Carbon Particle Suspension. Randomized Clinical Trial.
Endoscopic tattooing to facilitate colorectal lesions' identification during laparoscopic surgery is a reliable and widely used technique.
India Ink is the standard option for colonic tattoing. Different studies have been reported significant complications, of which the most common is peritonitis, due to ethylene glycol, phenols and animal-derived gelatine contained in the ink. This local inflammatory reaction is the principal reason of the formation of the adhesions detected during the laparoscopy, that make the intervention more difficult. To prevent infection or inflammatory local reaction India ink solution has to be sterilized and diluted, a cumbersome process. In the last years wide diffusion of another endoscopic ink, Sterile Carbon Particle Suspension, has reduced these complications. Sterile Carbon Particle Suspension is a prepackaged, sterile, FDA-approved formulation of pure carbon particle in suspension, that eliminates the need for preinjection preparation.
In an attempt to evaluate safety and efficacy of endoscopic tattooing in colorectal surgery using two different types of ink, a randomized clinical trial has been designed. Two types of endoscopic ink were evaluated: Sterile Carbon Particle Suspension (Experimental group) and India Ink (Control group) and.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Naples, Italy, 80131
- University of Naples Federico II
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
histologically confirmed malignancy planned for an elective, segmental laparoscopic colectomy.
Exclusion Criteria:
emergency surgery open surgery immune depressant disease immune depressant medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: India ink tattooing
Experimental group includes patients undergone to preoperative endoscopic tattooing with Sterile Carbon Particle Suspension.
|
The tattoo has to be placed 1 or 2 cm distal to the lesion and tattooing has to be performed in at least 2 of the 4 quadrants of the bowel.
A 0.5-1 mL saline bleb has to be raised submucosally and then a similar quantity of India Ink or Sterile Carbon Particle Suspension has to be injectiected into that bleb.
|
|
Experimental: Sterile Carbon Particle Suspension tattooing
Control group includes patients undergone to preoperative endoscopic tattooing with India Ink.
|
The tattoo has to be placed 1 or 2 cm distal to the lesion and tattooing has to be performed in at least 2 of the 4 quadrants of the bowel.
A 0.5-1 mL saline bleb has to be raised submucosally and then a similar quantity of India Ink or Sterile Carbon Particle Suspension has to be injectiected into that bleb.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abdominal pain
Time Frame: 6 hours after tattooing
|
using VAS Scale (from 1 to 10)
|
6 hours after tattooing
|
|
Body Temperature
Time Frame: 6 hours after tattooing
|
6 hours after tattooing
|
|
|
Body Temperature
Time Frame: 24 hours after tattooing
|
24 hours after tattooing
|
|
|
White Blood Count
Time Frame: 6 hours after tattooing
|
6 hours after tattooing
|
|
|
White Blood Count
Time Frame: 24 hours after tattooing
|
24 hours after tattooing
|
|
|
C reactive protein
Time Frame: 6 hours after tattooing
|
6 hours after tattooing
|
|
|
C reactive protein
Time Frame: 24 hours after tattooing
|
24 hours after tattooing
|
|
|
Peritoneal adhesions
Time Frame: During operative colectomy
|
Intraoperative adhesions, detected during laparoscopy and classified using Zühlke classification ranging from 0 to 4
|
During operative colectomy
|
|
Visibility of the tattoo
Time Frame: During operative colectomy
|
During operative colectomy
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- tattooingunina
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety and Efficacy of Tattooing Substance
-
Bon Secours Pediatric Dental AssociatesUnknownSafety and Efficacy of Intranasal DexmedetomidineUnited States
-
Boston Children's HospitalTerminatedSafety and Efficacy of Sedation MedicationsUnited States
-
Taipei Medical University WanFang HospitalUnknownEfficacy and Safety of VATS Block
-
Ankara City Hospital BilkentUnknownEfficacy and Safety of Novel Bidirectional CannulaTurkey
-
Xijing HospitalUnknownThe Efficacy and Safety of Intranasal Dexmedetomidine
-
Population Health Research InstituteCharles University, Czech Republic; Centre hospitalier de l'Université de Montréal... and other collaboratorsCompletedthe Efficacy and Safety of Off-pump CABGCanada, China, Colombia, India, Chile, Argentina, Brazil, Czech Republic, France, Italy, Poland, Turkey, United Kingdom
-
Jiangsu Nhwa Pharmaceutical Co., Ltd.CompletedEfficacy and Safety of Mivacurium Chloride for Pediatric Patients
-
Biotronik SE & Co. KGCompleted
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
Clinical Trials on endoscopic tattooing
-
Seoul National University HospitalActive, not recruiting
-
University Hospitals of Derby and Burton NHS Foundation...CompletedBreast Cancer | Sentinel Lymph Node | Tattoo; Pigmentation | Axilla; BreastUnited Kingdom
-
All India Institute of Medical Sciences, BhubaneswarRecruitingNeoadjuvant Chemoimmunotherapy | Tattoo Skin Markers | Breast Cancer (Locally Advanced or Metastatic)India
-
St. Luke's-Roosevelt Hospital CenterWithdrawnAppendicitis | Pelvic Pain | GallstonesUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingCrohn Disease | Endoscopy, Gastrointestinal | Stricture; BowelChina
-
Massachusetts General HospitalCompleted
-
Medical University of ViennaRecruitingEsophageal AchalasiaAustria
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Professor Michael BourkeCompletedColonic PolypsAustralia